Adverse effects of statin therapy: perception vs. the evidence
Levels of lipoprotein(a) [Lp(a)] need to be reduced by substantially more than has been achieved in recent trials
Impact of Healthy Lifestyle Factors on Life Expectancies in the US Population
How much does plasma lipoprotein(a) need to be lowered to produce a clinically meaningful reduction in the risk of coronary heart disease?
The effects of Vitamin D supplementation on statin adherence
HEART UK Conference
This year’s 32nd HEART UK Annual Medical and Scientific Conference reflects the current challenges and innovations within the lipid community. Whilst bringing variety to the programme with a number of hot topics, each area was skilfully explored by the speakers and audience bringing greater insight and direction to our management of cardiovascular disease.
Jaqui Walker reports from the conference, held at the University of Warwick from July 4th–6th 2018.